Asthma in sickle cell disease

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 1138-1152

  Newaskar, Manisha ^a   Hardy, Karen A ^a   Morris, Claudia R ^b  

^a Bay Area Pediatric Pulmonary Medical Corporation   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

Airway hyper reactivity; Arginase; Arginine metabolome; Asthma; Asthma therapy; Nitric oxide; Obstructive lung disease; Proinflammatory state; Sickle cell disease

Indexed keywords

ARGINASE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; IPRATROPIUM BROMIDE PLUS SALBUTAMOL; LEUKOTRIENE; MONTELUKAST; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PREDNISONE; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CHEST SYNDROME; ADJUVANT THERAPY; AIRWAY OBSTRUCTION; ALLERGIC ASTHMA; ASTHMA; DISEASE EXACERBATION; DISEASE PREDISPOSITION; ENZYME METABOLISM; ERYTHROCYTE TRANSFUSION; FAMILY HISTORY; GENETIC PREDISPOSITION; HEMOLYSIS; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAST CELL; MORTALITY; PATHOPHYSIOLOGY; PATIENT MONITORING; PREVALENCE; QT PROLONGATION; RESPIRATORY EPITHELIUM; REVIEW; SICKLE CELL ANEMIA; STROKE; TH2 CELL;

ANEMIA, SICKLE CELL; ARGININE; ASTHMA; HUMANS; INCIDENCE; LEUKOTRIENES; LUNG; NITRIC OXIDE; PNEUMONIA;

EID: 79958112029     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.105     Document Type: Review

References (101)

1. CDC (2010) 2008 National Health Interview Survey (NHIS) Data.
2. Koumbourlis, A.C. et al. (2001) Prevalence and reversibility of lower airway obstruction in children wi th sickle cell disease. J. Pediatr. 138, 188-192. (Pubitemid 32156432)
3. Leong, M.A. et al. (1997) Airway hyperreactivity in children with sickle cell disease. J. Pediatr. 131(2), 278-283.
4. Ozbek, O.Y. et al. (2007) Airway hyperreactivity detected by methacholine challenge in children with sickle cell disease. Pediatr. Pulmonol. 42, 1187-1192. (Pubitemid 350231870)
5. Sen, N. et al. (2009) Pulmonary function and airway hyperresponsiveness in adults with sickle cell disease. Lung 187, 195-200.
6. Strunk, R.C. et al. (2008) Methacholine challenge in children with sickle cell disease: a case series. Pediatr. Pulmonol. 43, 924-929.
7. Field, J.J. et al. (2011) Airway hyperresponsiveness in children with sickle cell anemia. Chest 139(3), 563-568.
8. Weiss, S.T. et al. (1984) Airways responsiveness in a population sample of adults and children. Am. Rev. Respir. Dis. 129(6), 898-902. (Pubitemid 14111742)
9. Kato, G.J. et al. (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 107(6), 2279-2285. (Pubitemid 43345545)
10. Knight-Madden, J. et al. (2005) Asthma in children with sickle cell disease and its association with acute chest syndrome. Thorax 60, 206-210. (Pubitemid 40380278)
11. Boyd, J.H. et al. (2004) Asthma and acute chest in sickle-cell disease. Pediatr. Pulmonol. 38, 229-232. (Pubitemid 39095681)
12. Boyd, J.H. et al. (2006) Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. Blood 108, 2923-2927.
13. Boyd, J.H. et al. (2009) Lower airway obstruction is associated with increased morbidity in children with sickle cell disease. Pediatr. Pulmonol. 44(3), 290-296.
14. Nordness, M.E. et al. (2005) Asthma is a risk factor for acute chest syndrome and cerebral vascular accidents in children with sickle cell disease. Clin. Mol. Allergy 3(1), 2.
15. Boyd, J.H. et al. (2007) Asthma is associated with increased mortality in individuals with sickle cell anemia. Haematologica 92, 1115-1118. (Pubitemid 350144219)
16. Hagar, R.W. et al. (2008) Clinical differences between children and adults with pulmonary hypertension and sickle cell disease. Br. J. Haematol. 140, 104-112. (Pubitemid 350233240)
17. NHLBI (2007) Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. National Asthma Education and Prevention Program. National Heart, Lung, and Blood Institute, Bethesda, MD.
18. Larché, M., Robinson, D.S., and Kay, A.B. (2003) The role of T lymphocytes in the pathogenesis of asthma. J. Allergy Clin. Immunol. 111(3), 450-463. (Pubitemid 36337859)
19. Zimmermann, N. et al. (2003) Chemokines in asthma: cooperative interaction between chemokines and IL-13. J. Allergy Clin. Immunol. 111(2), 227-242.
20. Rachelefsky, G. (1997) Childhood asthma and allergic rhinitis: the role of leukotrienes. J. Pediatr. 131, 348-355.
21. Hallstrand, T. and Henderson, W.R., Jr. (2010) An update on the role of leukotrienes in asthma. Curr. Opin. Allergy Clin. Immunol. 10, 60-66.
22. Stone, K.D., Prussin, C., and Metcalfe, D.D. (2010) IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol. 125, S73-80.
23. Robinson, D. (2004) The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle? J. Allergy Clin. Immunol. 114(1), 58-65.
24. Lamblin, C. et al. (1998) Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am. J. Respir. Crit. Care Med. 157(2), 394-402. (Pubitemid 28090526)
25. Morris, C.R. et al. (2004) Decreased arginine bioavailability and increased serum arginase activity in asthma. Am. J. Respir. Crit. Care Med. 170, 148-153. (Pubitemid 38925160)
26. Meurs, H., Maarsingh, H., and Zaagsma, J. (2003) Arginase and asthma: novel insights into nitric oxide homeostasis and airway hyperresponsiveness. Trends Pharmacol. Sci. 24(9), 450-455. (Pubitemid 37088169)
27. Lara, A. et al. (2008) Alterations of the arginine metabolome in asthma. Am. J. Respir. Crit. Care Med. 178, 673-681.
28. Ricciardolo, F.L.M. et al. (2004) Nitric oxide in health and disease of the respiratory system. Physiol. Rev. 84(3), 731-765. (Pubitemid 38823765)
29. North, M.L. et al. (2010) Arginase in asthma - recent developments in animal and human studies. Open Nitric Oxide J. 2, 20-36.
30. Kharitonov, S. et al. (1995) Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am. J. Respir. Crit. Care Med. 151(6), 1894-1899.
31. Jatakanon, A. et al. (1998) Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 53(2), 91-95.
32. de Boer, J. et al. (2001) Role of nitric oxide and superoxide in allergen-induced airway hyperreactivity after the late asthmatic reaction in guinea-pigs. Br. J. Pharmacol. 133(8), 1235-1242.
33. Maarsingh, H. et al. (2009) L-arginine deficiency causes airway hyperresponsiveness after the late asthmatic reaction. Eur. Respir. J. 34(1), 191-199.
34. Takemoto, K. et al. (2007) Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. Am. J. Physiol. Lung Cell. Mol. Physiol. 293(6), L1419-L1426. (Pubitemid 350255024)
35. Reynolds, J., Follette, J., and Valentine, W. (1957) The arginase activity of erythrocytes and leukocytes with particular reference to pernicious anemia and thalessemia major. J. Lab. Clin. Med. 50, 78-92.
36. Kim, P. et al. (2002) Expression of the liver form of arginase in erythrocyte. Mol. Genet. Metab. 76, 100-110. (Pubitemid 34757133)
37. Azizi, E., Dror, Y., and Wallis, K. (1970) Arginase activity in erythrocytes of healthy and ill children. Clin. Chim. Acta 28, 391-396.
38. Morris, C.R., (2010) Role of arginase in sickle cell lung disease and hemolytic anemias. Open Nitric Oxide J. 2, 41-54.
39. Zimmermann, N. et al. (2003) Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J. Clin. Invest. 111, 1863-1874. (Pubitemid 38057731)
40. Field, J.J. et al. (2011) Death due to asthma in two adolescents with sickle cell disease. Pediatr. Blood Cancer 56(3), 454-457.
41. Pathare, A. et al. (2004) Cytokine profile of sickle cell disease in Oman. Am. J. Hematol. 77, 323-328. (Pubitemid 39578309)
42. Duits, A. et al. (1996) Enhanced levels of soluble VCAM-1 in sickle cell patients and their specific increment during vasoocclusive crisis. Clin. Immunol. Immunopathol. 81(1), 96-98. (Pubitemid 26338254)
43. Morris, C.R. et al. (2000) Patterns of arginine and nitric oxide in patients with sickle cell disease with vaso-occlusive crisis and acute chest syndrome. J. Pediatr. Hematol. Oncol. 22(6), 515-520.
44. Holtzclaw, J.D. et al. (2004) Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice. Am. J. Respir. Crit. Care Med. 169, 687-695. (Pubitemid 38338920)
45. Nandedkar, S.D. et al. (2008) Histopathology of experimentally induced asthma in a murine model of sickle cell disease. Blood 112, 2529-2538.
46. Wallace, K.L. et al. (2009) NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood 114(3), 667-676.
47. Field, J.J. et al. (2009) Urinary cysteinyl leukotriene E4 is associated wtih increased risk for pain and acute chest syndrome in adults with sickle cell disease. Am. J. Hematol. 84, 158-160.
48. Field, J.J. et al. (2009) Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease. Am. J. Hematol. 84, 231-233.
49. Jennings, J.E. et al. (2008) Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease. Am. J. Hematol. 83, 640-643.
50. Styles, L. et al. (1996) Phospholipase A2 levels in acute chest syndrome of sickle cell disease. Blood 87, 2573-2578. (Pubitemid 26086904)
51. Styles, L.A. et al. (2007) Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br. J. Haematol. 136(2), 343-344. (Pubitemid 46020766)
52. Bowton, D.L. et al. (1997) Phospholipase A2 and arachidonate increase in bronchoalveolar lavage fluid after inhaled antigen challenge in asthmatics. Am. J. Respir. Crit. Care Med. 155(2), 421-425. (Pubitemid 27085779)
53. Palmblad, J. et al. (1981) Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood 58(3), 658-661. (Pubitemid 11002774)
54. Setty, Y.B.S. and Stuart, M.J. (2002) Eicosanoids in sickle cell disease: potential relevance of neutrophil leukotriene B4 to disease pathophysiology. J. Lab. Clin. Med. 139(2), 80-89.
55. Johnson, H.G. and McNee, M.L. (1983) Secretogogue responses of leukotriene C4, D4: comparison of potency in canine trachea in vivo. Prostaglandins 25(2), 237-243. (Pubitemid 13047714)
56. Dahlen, S.E. et al. (1980) Leukotrienes are potent constrictors of human bronchi. Nature 288(5790), 484-486. (Pubitemid 11163960)
57. Morris, C.R. et al. (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension and mortality in sickle cell disease. JAMA 294(1), 81-90. (Pubitemid 41002842)
58. Rother, R. et al. (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293(13), 1653-1662. (Pubitemid 40471796)
59. Barnes, P.J. et al. (2010) Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 138(3), 682-692.
60. Girgis, R.E. et al. (2003) Decreased exhaled nitric oxide in sickle cell disease: relationship with chronic lung involvement. Am. J. Hematol. 72(3), 177-184. (Pubitemid 36258608)
61. Sullivan, K.J. et al. (2001) Low exhaled nitric oxide and a polymorphism in the NOS I gene is associated with acute chest syndrome. Am. J. Respir. Crit. Care Med. 164, 2186-2190. (Pubitemid 34032933)
62. Hebbel, R.P. et al. (1982) Spontaneous oxygen radical generation by sickle erythrocytes. J. Clin. Invest. 70(6), 1253-1259. (Pubitemid 13168006)
63. Wood, K.C. and Granger, D.N. (2007) Sickle cell disease: role of reactive oxygen and nitrogen metabolites. Clin. Exp. Pharmacol. Physiol. 34(9), 926-932. (Pubitemid 47083959)
64. Xia, Y. et al. (1996) Nitric oxide synthase generates superoxide and nitric oxide in arginine-depleted cells leading to peroxynitrite-mediated cellular injury. Proc. Natl. Acad. Sci. U. S. A. 93(13), 6770-6774.
65. Morris, C.R. (2008) Mechanisms of vasculopathy in sickle cell disease and thalessemia. Hematology Am. Soc. Hematol. Educ. Program 177-185.
66. Gordeuk, V.R. et al. (2011) Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia. Haematologica 96(1), 33-40.
67. Morris, C.R. (2011) Vascular risk assessment in patients with sickle cell disease. Haematologica 96(1), 1-5.
68. Morris, C.R. (2009) Asthma management: reinventing the wheel in sickle cell disease. Am. J. Hematol. 84(4), 234-241.
69. Kato, G.J., Gladwin, M.T., and Steinberg, M.H. (2007) Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 21(1), 37-47. (Pubitemid 46110926)
70. Phillips, K.L. et al. (2008) Major gene effect and additive familial pattern of inheritance of asthma exist among families of probands with sickle cell anemia and asthma. Am. J. Hum. Biol. 20, 149-153. (Pubitemid 351425240)
71. Field, J.J. et al. (2008) Sibling history of asthma is a risk factor for pain in children with sickle cell anemia. Am. J. Hematol. 83(11), 855-857.
72. Duckworth, L.J. et al. (2007) Physician-diagnosed asthma and acute chest syndrome: associations with NOS polymorphisms. Pediatr. Pulmonol. 42, 332-338.
73. Sharan, K. et al. (2004) Association of T-786C eNOS gene polymorphism with increased susceptibility to acute chest syndrome in females with sickle cell disease. Br. J. Haematol. 124(2), 240-243. (Pubitemid 38122198)
74. Chaar, V. et al. (2006) ET-1 and ecNOS gene polymorphisms and susceptibility to acute chest syndrome and painful vaso-occlusive crises in children with sickle cell anemia. Haematologica 91(9), 1277-1278. (Pubitemid 44408445)
75. Sylvester, K. et al. (2004) Pulmonary function abnormalities in children with sickle cell disease. Thorax 59, 69-70.
76. Knight-Madden, J. et al. (2010) The impact of recurrent acute chest syndrome on the lung function in young adults with sickle cell disease. Lung 188, 499-504.
77. Klings, E.S. et al. (2006) Abnormal pulmonary function in adults with sickle cell anemia. Am. J. Respir. Crit. Care Med. 173(11), 1264-1269. (Pubitemid 43848398)
78. Koumbourlis, A.C., Hurlet-Jensen, A., and Bye, M.R. (1997) Lung function in infants with sickle cell disease. Pediatr. Pulmonol. 24, 277-281. (Pubitemid 27484205)
79. MacLean, J.E. et al. (2008) Longitudinal decline in lung volume in a population of children with sickle cell disease. Am. J. Respir. Crit. Care Med. 178, 1055-1059.
80. Walters, M.C. et al. (2010) Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol. Blood Marrow Transplant. 16(2), 263-272.
81. Knight-Perry, J.E. et al. (2009) Hospital admission for acute painful episode following methacholine challenge in an adolescent with sickle cell disease. Pediatr. Pulmonol. 44, 728-730.
82. Nelson, H.S. et al. (2006) The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129(1), 15-26. (Pubitemid 43265239)
83. Liem, R.I., Young, L.T., and Thompson, A.A. (2009) Prolonged QTc interval in children and young adults with sickle cell disease at steady state. Pediatr. Blood Cancer 52, 842-846.
84. Thottathil, P. et al. (2008) Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta2-agonists. Am. J. Cardiol. 102, 871-874.
85. Strouse, J.J. et al. (2008) Corticosteroids and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatr. Blood Cancer 50(5), 1006-1012. (Pubitemid 351500179)
86. Sobota, A. et al. (2010) Corticosteroids for acute chest syndrome in children with sickle cell disease: variation in use and association with length of stay and readmission. Am. J. Hematol. 85, 24-28.
87. Bernini, J.C. et al. (1998) Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood 92, 3082-3089. (Pubitemid 28492313)
88. Kumar, R. et al. (2010) A short course of prednisone in the management of acute chest syndrome of sickle cell disease. J. Pediatr. Hematol. Oncol. 32, e91-e94.
89. Couillard, S. et al. (2007) Steroid treatment in children with sickle-cell disease. Haematologica 92, 425-426. (Pubitemid 350143558)
90. Rees, D.C., Williams, T.N., and Gladwin, M.T. (2010) Sickle-cell disease. Lancet 376(9757), 2018-2031.
91. Charache, S. et al. (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. N. Engl. J. Med. 332(20), 1317-1322.
92. Singh, S.A., Koumbourlis, A.C., and Aygun, B. (2008) Resolution of chronic hypoxemia in pediatric sickle cell patients after treatment with hydroxyurea. Pediatr. Blood Cancer 50, 1258-1286.
93. Rastogi, D. et al. (2006) National Heart, Lung, and Blood Institute guidelines and asthma management practices among inner-city pediatric primary care providers. Chest 129(3), 619-623.
94. Moore, W.C. (2008) Update in asthma 2007. Am. J. Respir. Crit. Care Med. 177(10), 1068-1073.
95. Denlinger, L.C. et al. (2007) Guideline-defining asthma clinical trials of the National Heart, Lung, and Blood Institute's Asthma Clinical Research Network and Childhood Asthma Research and Education Network. J. Allergy Clin. Immunol. 119(1), 3-11; quiz 12-13.
96. Gladman, D.D. and Bombardier, C. (1987) Sickle cell crisis following intraarticular steroid therapy for rheumatoid arthritis. Arthritis Rheum. 30(9), 1065-1068. (Pubitemid 17149919)
97. Darbari, D.S. et al. (2008) Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease. J. Natl. Med. Assoc. 100(8), 948-951.
98. Griffin, T.C., McIntire, D., and Buchanan, G.R. (1994) High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease. N. Engl. J. Med. 330(11), 733-737. (Pubitemid 24080218)
99. Reiter, C. et al. (2002) Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8(12), 1383-1389. (Pubitemid 36019423)
100. Hsu, L.L. et al. (2007) Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 109(7), 3088-3098. (Pubitemid 46482112)
101. Dias-Da-Motta, P. et al. (1996) The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia. Br. J. Haematol. 1996(93), 2.